Stock 2190 ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Zylox-Tonbridge Medical Technology Co., Ltd.

Equities

2190

CNE100004JD2

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:07 2024-06-03 am EDT 		5-day change 1st Jan Change
11.16 HKD +1.09% Intraday chart for Zylox-Tonbridge Medical Technology Co., Ltd. +5.68% -10.29%
May. 09 Zylox-Tonbridge Medical Technology Co., Ltd. Announces Retirement of Hongze Liang as an Independent Non-Executive Director CI
Mar. 22 Zylox-Tonbridge Shrinks Loss by 31% in Fiscal 2023 MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Zylox-Tonbridge Medical Technology Co., Ltd. Announces Retirement of Hongze Liang as an Independent Non-Executive Director
CI
Zylox-Tonbridge Shrinks Loss by 31% in Fiscal 2023
MT
Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Avinger in Equity Funding Partnership With Chinese Medical Device Firm, Unveils Debt-Terms Extension; Shares Rise Premarket
MT
Zylox-Tonbridge Enters Licensing, Investment Contracts with American Innovative Medical Device Maker
MT
Avinger, Inc. Announces New Strategic Partnership with Zylox-Tonbridge Medical Technology Co., Ltd
CI
Avinger, Inc. announced that it expects to receive $15 million in funding from Zylox-Tonbridge Medical Technology Co., Ltd.
CI
Zylox-Tonbridge Receives Marketing Approvals for Multiple Products in the UAE
CI
China Grants Marketing Approval to Zylox-Tonbridge's Peripheral Venous Stent System; Shares Fall 7%
MT
Zylox-Tonbridge Medical Technology Co., Ltd Receives Marketing Approval from National Medical Products Administration Grants Marketing for Zylox® Penguin Peripheral Venous Stent System
CI
Zylox-Tonbridge Medical Technology Co., Ltd. Announces National Medical Products Administration Grants Marketing Approval for Zylox Phoenix Peripheral Detachable Fibrous Coil Embolization System
CI
Zylox Tonbridge Secures Chinese Marketing Approval for Arterial Embolization Device
MT
Zylox-Tonbridge Completes Patient Enrolment for Post-Marketing Clinical Trial of Stent System in EU
MT
Zylox-Tonbridge Medical Technology Co., Ltd. Completes Enrollment of All 100 Patients in the Multi-Center Clinical Trial in Germany
CI
Zylox-Tonbridge Medical Technology Co., Ltd. Receives Official Marketing Approval
CI
China Grants Marketing Approval to Zylox-Tonbridge's Balloon Catheter
MT
China Gives Marketing Approval for Zylox-Tonbridge's Blood Vessel Distal Support Catheter
MT
Zylox-Tonbridge Medical Technology Co., Ltd. Announces Change of Address of Registered Office
CI
Zylox-Tonbridge Medical Technology Co., Ltd. commences an Equity Buyback Plan for 32,461,974 shares, representing 10% of its issued share capital, under the authorization approved on June 6, 2023.
CI
Zylox-Tonbridge Trustee Buys About 1.1 Million Shares Under Share Award, Trust Scheme; Shares Jump 5%
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 2190 Stock
  4. News Zylox-Tonbridge Medical Technology Co., Ltd.